Substitute House Bill No. 6436, now Public Act No. 25-132, introduces several revisions to the health insurance statutes, effective from October 1, 2025. The bill establishes a health benefit review program within the Insurance Department to evaluate mandated health benefits as requested by the General Assembly's insurance committee. This program will be funded by the Insurance Fund, with the commissioner authorized to make assessments for its costs. Notably, the bill modifies the previous requirement for the commissioner to contract with The University of Connecticut Center for Public Health and Health Policy, allowing instead for the engagement of various independent experts as deemed necessary for the review process.

Additionally, the bill revises reporting requirements for pharmacy benefits managers, extending the deadline for annual reports from February 1, 2025, to March 1, 2026, and subsequently each year. The reports must include detailed information on rebates from pharmaceutical manufacturers related to outpatient prescription drugs. The commissioner is tasked with creating a standardized reporting form to ease the administrative burden and ensuring that submitted information remains confidential under the Freedom of Information Act. The bill also grants the commissioner the authority to impose penalties for violations and to adopt regulations for implementation, replacing previous mandatory language with discretionary terms.

Statutes affected:
Raised Bill:
INS Joint Favorable:
File No. 53:
Public Act No. 25-132: